STEM CELLSPub Date : 2026-08-22DOI: 10.1093/stmcls/sxag041
Sungmin Kim, Hye-Ju Jo, Sung-Hwan Moon
{"title":"Engineering neural organoids: technological advances and translational frontiers.","authors":"Sungmin Kim, Hye-Ju Jo, Sung-Hwan Moon","doi":"10.1093/stmcls/sxag041","DOIUrl":"10.1093/stmcls/sxag041","url":null,"abstract":"<p><p>Neural organoids have transformed experimental neuroscience by enabling human-specific models of brain development, function, and disease. Emerging at the intersection of stem cell biology and tissue engineering, these self-organizing systems recapitulate key aspects of neurogenesis, gliogenesis, and circuit formation within a controllable in vitro context. Advances in guided patterning, vascularization, and electrophysiological monitoring have enhanced structural and functional fidelity, enabling the study of dynamic processes previously inaccessible in human models. Beyond developmental biology, neural organoids have broad translational applications, including modeling neurodevelopmental and neurodegenerative disorders, screening pharmacological compounds, and testing regenerative strategies. Integration with microfluidics, bioelectronic interfaces, and computational modeling further expands their analytical capacity, transforming organoids into modular and quantifiable platforms for mechanistic and therapeutic discovery. Despite this progress, key challenges remain, including limited maturation, inter-organoid variability, and incomplete physiological integration. Addressing these limitations requires standardized differentiation protocols, robust functional benchmarks, and cross-disciplinary collaboration. The goal is not to replicate the brain in miniature, but to reconstruct its organizing principles in an experimentally accessible system. From this perspective, neural organoids serve as a bridge between biology and technology, offering new insights into human neural complexity while advancing neuroscience and medicine.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148519694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-08-22DOI: 10.1093/stmcls/sxag044
Yusuke Nishimura
{"title":"Function-first organoid engineering for regenerative medicine: current challenges and future perspectives.","authors":"Yusuke Nishimura","doi":"10.1093/stmcls/sxag044","DOIUrl":"10.1093/stmcls/sxag044","url":null,"abstract":"<p><p>Organoid technology has emerged as a powerful platform for modeling human development, disease, and drug responses. Advances in stem cell biology and bioengineering have enabled the generation of increasingly sophisticated organoid systems that recapitulate key structural and cellular features of native tissues. However, despite substantial progress, the translational impact of organoids in regenerative medicine remains limited. Greater structural complexity and anatomical resemblance have not consistently translated into sustained therapeutic function or clinical applicability. Major barriers include incomplete maturation, inadequate vascular and immune integration, limited long-term functional stability, and challenges in reproducibility and scalability. These limitations reflect a conceptual mismatch between structure-driven organoid development and the functional requirements of regenerative medicine. Here, we propose a function-first framework in which regenerative organoids are engineered and evaluated according to measurable therapeutic outcomes, including tissue-specific function, vascular integration, immune compatibility, reproducibility, scalability, and long-term stability. We further discuss emerging bioengineering strategies, including vascularization, immune incorporation, organ-on-a-chip platforms, advanced biomaterials, and automated manufacturing, that may accelerate clinical translation. Reframing organoids as functionally engineered therapeutic platforms rather than increasingly complex anatomical models provides a conceptual foundation for advancing regenerative organoid therapies.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-08-22DOI: 10.1093/stmcls/sxag042
Jinyu Ma, Xingli Hu, Xinfeng Liu, Meijiao Qi, Liwen Shi, Meng Chen, Yan Xie, Baoli Wang, Jie Zhou
{"title":"Vacuolar protein sorting 4B is a novel regulator of osteoblast and adipocyte differentiation by activating autophagy signaling.","authors":"Jinyu Ma, Xingli Hu, Xinfeng Liu, Meijiao Qi, Liwen Shi, Meng Chen, Yan Xie, Baoli Wang, Jie Zhou","doi":"10.1093/stmcls/sxag042","DOIUrl":"10.1093/stmcls/sxag042","url":null,"abstract":"<p><p>Vacuolar protein sorting 4B (VPS4B) is part of the endosomal sorting complex required for the transport machinery and is essential for autophagosome completion. Vps4b mutation might reduce the ability of dental follicle cells to differentiate during the mineralization process. However, the role of VPS4B in osteogenic and adipogenic differentiation from mesenchymal stem/progenitor cells remains to be explored. In the present study, we observed a substantial presence of VPS4B in bone, as well as an increase in its expression levels during the osteogenic and adipogenic differentiation of mesenchymal progenitor cells. Functional experiments revealed that VPS4B facilitated the differentiation of both osteoblasts and adipocytes. Further mechanistic investigations revealed that VPS4B was involved in autophagy in mesenchymal progenitor cells and the positive influence of VPS4B on osteogenic and adipogenic differentiation was mitigated in the context of autophagy inhibition, indicating that the pro-osteogenic and pro-adipogenic effects of VPS4B are dependent on the autophagy signaling pathway. Our research suggests that sustaining VPS4B expression at an optimal level may be advantageous for the maintenance of bone and fat homeostasis.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148589863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag032
Xinran Zhao, Jie Wen, Yijian Yao, Yi Qin, Xingyu Du, Jin Liu, Luyao Wang, Xiaozhong Li, Xiaoxia Wang
{"title":"Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.","authors":"Xinran Zhao, Jie Wen, Yijian Yao, Yi Qin, Xingyu Du, Jin Liu, Luyao Wang, Xiaozhong Li, Xiaoxia Wang","doi":"10.1093/stmcls/sxag032","DOIUrl":"10.1093/stmcls/sxag032","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer (BC) has a high incidence and mortality rate among women. Doxorubicin (DOX) is one of the standard chemotherapeutic drugs for BC. However, chemoresistance to DOX represents a major therapeutic obstacle, and its underlying mechanisms remain elusive. CircEGFR (hsa_circ_0080222) is significantly upregulated in BC tissues and drives the malignant progression of BC. However, the role of circEGFR in DOX resistance remains unclear.</p><p><strong>Methods: </strong>MTT and colony formation assays were used to assess cell growth. Quantitative real‑time PCR and western blot were performed to examine gene expression at the mRNA and protein levels, respectively. Spheroid formation and ALDH activity assays were employed to evaluate cell stemness. RNA immunoprecipitation was used to explore the interaction between circEGFR and IGF2BP2.</p><p><strong>Results: </strong>CircEGFR expression was significantly upregulated in DOX-resistant MCF-7 (MCF-7/DOX) cells. CircEGFR overexpression attenuated DOX sensitivity in MCF-7 cells, as evidenced by increased cell viability and enhanced proliferative capacity. Notably, circEGFR also enhanced cancer stem cell (CSC) properties in BC cells. Conversely, circEGFR knockdown reduced chemoresistance and stem-like properties in both MDA-MB-231 and MCF-7/DOX cells. Mechanistically, circEGFR interacted with IGF2BP2 to enhance the stability of the stem cell marker SOX2 mRNA, resulting in elevated SOX2 expression. Rescue experiments demonstrated that silencing IGF2BP2 or SOX2 abrogated circEGFR-mediated chemoresistance and stemness properties in BC cells.</p><p><strong>Conclusion: </strong>Our study demonstrates for the first time that circEGFR drives DOX chemoresistance and maintains cancer stemness in BC cells via the IGF2BP2/SOX2 axis. Targeting circEGFR may be considered a promising therapeutic strategy for overcoming chemotherapy resistance in BC.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147985905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag034
{"title":"Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors.","authors":"","doi":"10.1093/stmcls/sxag034","DOIUrl":"https://doi.org/10.1093/stmcls/sxag034","url":null,"abstract":"","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":"44 8","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148617498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag029
Olena Zhulyn, Vanessa Donega
{"title":"Regeneration of the mammalian brain: a relic of evolution?","authors":"Olena Zhulyn, Vanessa Donega","doi":"10.1093/stmcls/sxag029","DOIUrl":"10.1093/stmcls/sxag029","url":null,"abstract":"<p><p>Compared to amphibians, fish, and reptiles, mammals have an impaired capacity to regenerate the brain, despite the presence of a neural stem cell pool. Here, we consider the biological significance of a stem cell source in the human brain by exploring evolutionary trade-offs that may guide retention of regenerative capacity in mammals and the risks and benefits of active neurogenesis in adults. We discuss whether reduced regenerative capacity in humans is adaptive or stochastic and examine the role of the injured and diseased brain environment in preventing efficient brain repair. We discuss the therapeutic potential of activating the latent regenerative potential of the human brain to reverse tissue damage or degeneration and whether this approach carries with it an unanticipated risk of cancer.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13445984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147872590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag039
Prabin Upadhyaya
{"title":"Human iPSC-derived 3D cardiac models for cardiomyopathies: organoids, spheroids, and engineered heart tissues as translational platforms.","authors":"Prabin Upadhyaya","doi":"10.1093/stmcls/sxag039","DOIUrl":"10.1093/stmcls/sxag039","url":null,"abstract":"<p><p>Cardiomyopathies represent a substantial global health burden, yet progress in developing effective therapies was long constrained by the absence of physiologically relevant human models to understand molecular mechanisms and evaluating interventions. The advent of induced pluripotent stem cell (iPSC) technology has driven major advances in cardiomyopathy research, although important limitations persist. Current iPSC-based systems exhibit incomplete cellular maturation, lack functional vasculature and chamber level architecture, and possess an immature extracellular matrix. These factors must be carefully weighed when interpreting disease phenotypes and drug response data. Induced pluripotent stem cell-derived in vitro three-dimensional (3D) cardiac tissues have significantly addressed these issues, thereby expanding our ability to model human cardiac disease, offering more physiologically relevant platforms for mechanistic studies, drug screening, and translational research. This concise review synthesizes recent advances in the development of iPSC-derived 3D cardiac systems, such as 3D spheroids, engineered heart tissues, and cardiac organoids, their application to modeling various cardiomyopathies including hypertrophic cardiomyopathy, dilated cardiomyopathy, and amyloid-related cardiomyopathies, while discussing critical challenges including cellular maturation, vascularization, and standardization. In this review, emerging technologies and therapeutic strategies have been highlighted that bridge the gap between bench and bedside, demonstrating the translational potential of these models for precision medicine in cardiovascular disease.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13452171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148409788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag033
Xiaochen Fan, Emine K Bilir, Olivia A Kingston, Victoria R Kearns, Colin E Willoughby, Carl M Sheridan
{"title":"Transforming growth factor beta-2 drives trabecular meshwork progenitor cell differentiation through SMAD2/3 signaling.","authors":"Xiaochen Fan, Emine K Bilir, Olivia A Kingston, Victoria R Kearns, Colin E Willoughby, Carl M Sheridan","doi":"10.1093/stmcls/sxag033","DOIUrl":"10.1093/stmcls/sxag033","url":null,"abstract":"<p><p>Primary open-angle glaucoma (POAG) is a major cause of irreversible blindness, yet its underly mechanisms remain unclear. Elevated intraocular pressure (IOP), the only modifiable risk factor for POAG, arises from increased resistance to aqueous humor outflow within the conventional outflow pathway, which comprises the trabecular meshwork (TM) and the inner wall of Schlemm's canal. Dysfunction and cellular loss within this pathway, particularly in the TM, are consistent features of the disease; however, the mechanisms responsible for impaired tissue maintenance and regenerative failure remain unclear. TM progenitor cells (TMPCs) have the capacity to replace lost TM cells, suggesting that impaired progenitor function may contribute to disease progression. Transforming growth factor beta 2 (TGFβ2), which is consistently elevated in the aqueous humor of POAG patients, plays a key role in regulating stem cell differentiation. We proposed that excess TGFβ2 disrupts TMPC function, leading to progenitor depletion and TM dysfunction. Here, we show that TGFβ2 drives TMPCs toward a differentiated, fibrotic phenotype, increasing TM and profibrotic gene expression while reducing progenitor markers. These effects are mediated through TGFβ2-SMAD2/3 signaling, as inhibition of this pathway preserves TMPC characteristics and suppresses fibrotic gene induction. Our findings identify TGFβ2-SMAD2/3 signaling as a regulator of TMPC fate in vitro and suggest a potential mechanism by which elevated TGFβ2 may influence TMPC behavior under pathological conditions.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13446226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148025286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag018
Taiyan Ji, Jiajia Shi, Jing Yang
{"title":"Synergizing stem cells with biomaterials for therapeutic angiogenesis in ischemic diseases.","authors":"Taiyan Ji, Jiajia Shi, Jing Yang","doi":"10.1093/stmcls/sxag018","DOIUrl":"10.1093/stmcls/sxag018","url":null,"abstract":"<p><p>Therapeutic angiogenesis (TA) is a promising strategy for treating ischemic diseases, mainly by targeting the angiogenesis pathways and cells, particularly VEGF and endothelial progenitor cells. Although stem cell therapy has been extensively investigated, its clinical translation remains limited by challenges such as poor cell retention, low survival rates, and inefficient integration. In this review, we propose a mechanism-based framework of angiogenesis to discuss how biomaterials act synergistically with stem cells mainly through two distinct pathways: enhancing paracrine capacity and promoting direct differentiation of vascular lineage cells for vascular repair. Firstly, we go through the scientific literature and clinical studies, and summary the researches on biomaterials serve as artificial microenvironments to improve the retention and secretory function of mesenchymal stem cells (MSCs) and adipose-derived stem cells (ADSCs), thereby maximizing the release of angiogenic factors such as VEGF, bFGF, NGF, microRNA and so on. Secondly, we explore how functionalized biomaterials guide the in situ recruitment of endothelial progenitor cells (EPCs) and support the structural maturation of induced pluripotent stem cell (iPSC)-derived endothelial cells. By integrating these mechanism-driven approaches, we offer new perspectives on future directions for preclinical research and clinical translation of biomaterial-based therapies. Overall, this review has examined the role of individual stem cells and biomaterials, especially enhanced angiogenesis by stem cells focusing on their mechanisms of action and preclinical and clinical applications. We further discussed the challenges encountered by stem cell therapy in advancing to the stage of clinical transformation and considered future prospects.</p>","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147643405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
STEM CELLSPub Date : 2026-07-22DOI: 10.1093/stmcls/sxag040
{"title":"Correction to: Lack of a p21waf1/cip-Dependent G1/S Checkpoint in Neural Stem and Progenitor Cells After DNA Damage In Vivo.","authors":"","doi":"10.1093/stmcls/sxag040","DOIUrl":"https://doi.org/10.1093/stmcls/sxag040","url":null,"abstract":"","PeriodicalId":231,"journal":{"name":"STEM CELLS","volume":"44 8","pages":""},"PeriodicalIF":4.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148756989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}